{"id":949206,"date":"2026-04-06T16:27:30","date_gmt":"2026-04-06T20:27:30","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-inovio-pharmaceuticals-inc-ino-shareholders\/"},"modified":"2026-04-06T16:27:30","modified_gmt":"2026-04-06T20:27:30","slug":"levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-inovio-pharmaceuticals-inc-ino-shareholders","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-inovio-pharmaceuticals-inc-ino-shareholders\/","title":{"rendered":"Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of Inovio Pharmaceuticals, Inc.(INO) Shareholders"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK, April  06, 2026  (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in\u00a0<strong>Inovio Pharmaceuticals, Inc.<\/strong> (&#8220;Inovio Pharmaceuticals, Inc.&#8221; or the &#8220;Company&#8221;) (NASDAQ: INO) of a class action securities lawsuit.<\/p>\n<p>\n        <strong>CLASS DEFINITION: <\/strong>The lawsuit seeks to recover losses on behalf of Inovio Pharmaceuticals, Inc. investors who were adversely affected by alleged securities fraud between October 10, 2023 and December 26, 2025. Follow the link below to get more information and be contacted by a member of our team:<\/p>\n<p align=\"center\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2gKA0VwgWR66Kgwi2sfc0HO8Ia2Xe0r2FPQ219xllKGQJVXTL0_2ILIx0v2_XzQm72icdWu-jURMgojRDpUxilPg5PFHXoxWZC_5EwrUDpEUBz7uH_lnkEZt8l4IJ1tbsuJ3rkpdE_GLFUVoEDURpZpTG7A3QHFtstt_UEK4_sUuysjOXc0TfMp7udx8yCvBCG6Kp46c7XQPNlT7RtMZ0-xrPeoyHjiredZVsWqsUMOKFSnrxjxUuiK6w2S1jkFi7Kvg173R7NyNnMAzBv-10kxDHbhhg8QTCsiRiX0ia3c=\" rel=\"nofollow\" target=\"_blank\">https:\/\/zlk.com\/pslra-1\/inovio-pharmaceuticals-inc-lawsuit-submission-form?prid=185172&amp;wire=3<\/a>\n      <\/p>\n<p>\n        <strong>INO<\/strong> investors may also contact Joseph E. Levi, Esq. via email at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=iVo0Zg9zScZVJ-tErcFVo4Yhegrcu7trwWWDJtqdyCfVDozP5PT5nraEcERKSFiOG0czLsVXSdKnbrdpgpH3g2LZg4l3JqCJWYSsOChMkV8=\" rel=\"nofollow\" target=\"_blank\">jlevi@levikorsinsky.com<\/a>\u00a0or by telephone at (212) 363-7500.<\/p>\n<p>\n        <strong>CASE DETAILS: <\/strong>The filed complaint alleges that defendants made false statements and\/or concealed that: (i) manufacturing for Inovio\u2019s CELLECTRA device was deficient; (ii) accordingly, Inovio was unlikely to submit its lead product candidate, INO-3107 BLA to the FDA by the second half of 2024; (iii) Inovio had insufficient information to justify the INO-3107 BLA\u2019s eligibility for FDA accelerated approval or priority review; (iv) accordingly, INO-3107\u2019s overall regulatory and commercial prospects were overstated; and (v) as a result, defendants\u2019 public statements were materially false and misleading at all relevant times.<\/p>\n<p>\n        <strong>WHAT&#8217;S NEXT? <\/strong>If you suffered a loss in Inovio Pharmaceuticals, Inc. during the relevant time frame, you have until <strong>April 7, 2026<\/strong>\u00a0to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn&#8217;t require that you serve as a lead plaintiff.<\/p>\n<p>\n        <strong>NO COST TO YOU: <\/strong>If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. <strong>There is no cost or obligation to participate.<\/strong><\/p>\n<p>\n        <strong>WHY LEVI &amp; KORSINSKY: <\/strong>Over the past 20 years, the team at Levi &amp; Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi &amp; Korsinsky has ranked in ISS Securities Class Action Services\u2019 Top 50 Report as one of the top securities litigation firms in the United States.<\/p>\n<p>\n        <strong>CONTACT:<\/strong><br \/>\n        <br \/>Levi &amp; Korsinsky, LLP <br \/>Joseph E. Levi, Esq.<br \/>Ed Korsinsky, Esq.<br \/>33 Whitehall Street, 27th Floor<br \/>New York, NY 10004<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=iVo0Zg9zScZVJ-tErcFVo4Yhegrcu7trwWWDJtqdyCc8t7Jh4e_PHyAAyiV_raJ22_JJuEkvmwdcMyooYAQMJToddJ4kBUDWR3HlqOJZn3E=\" rel=\"nofollow\" target=\"_blank\">jlevi@levikorsinsky.com<\/a><br \/>Tel: (212) 363-7500<br \/>Fax: (212) 363-7171<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=bnN0JcNKg6DznvXqLyVzkku_KXFUfsEEbCcasX8V927AcNzm7UfNlBKuc8bfGb9kjA-PPHs20KtcSBP1HDZrvA==\" rel=\"nofollow\" target=\"_blank\">www.zlk.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4MzA2NyM3NTE2NjA5IzIwMjA0MjY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YTc0ZmUyZjEtZTA0MS00NWRkLWI2MzYtZGRkOGI3MmViZTE3LTEwMzIyOTMtMjAyNi0wNC0wNi1lbg==\/tiny\/Levi-Korsinsky-LLP.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, April 06, 2026 (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in\u00a0Inovio Pharmaceuticals, Inc. (&#8220;Inovio Pharmaceuticals, Inc.&#8221; or the &#8220;Company&#8221;) (NASDAQ: INO) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Inovio Pharmaceuticals, Inc. investors who were adversely affected by alleged securities fraud between October 10, 2023 and December 26, 2025. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/inovio-pharmaceuticals-inc-lawsuit-submission-form?prid=185172&amp;wire=3 INO investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and\/or concealed that: (i) manufacturing for Inovio\u2019s CELLECTRA device was deficient; &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-inovio-pharmaceuticals-inc-ino-shareholders\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of Inovio Pharmaceuticals, Inc.(INO) Shareholders&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-949206","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of Inovio Pharmaceuticals, Inc.(INO) Shareholders - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-inovio-pharmaceuticals-inc-ino-shareholders\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of Inovio Pharmaceuticals, Inc.(INO) Shareholders - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, April 06, 2026 (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in\u00a0Inovio Pharmaceuticals, Inc. (&#8220;Inovio Pharmaceuticals, Inc.&#8221; or the &#8220;Company&#8221;) (NASDAQ: INO) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Inovio Pharmaceuticals, Inc. investors who were adversely affected by alleged securities fraud between October 10, 2023 and December 26, 2025. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/inovio-pharmaceuticals-inc-lawsuit-submission-form?prid=185172&amp;wire=3 INO investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and\/or concealed that: (i) manufacturing for Inovio\u2019s CELLECTRA device was deficient; &hellip; Continue reading &quot;Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of Inovio Pharmaceuticals, Inc.(INO) Shareholders&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-inovio-pharmaceuticals-inc-ino-shareholders\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-06T20:27:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4MzA2NyM3NTE2NjA5IzIwMjA0MjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-inovio-pharmaceuticals-inc-ino-shareholders\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-inovio-pharmaceuticals-inc-ino-shareholders\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of Inovio Pharmaceuticals, Inc.(INO) Shareholders\",\"datePublished\":\"2026-04-06T20:27:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-inovio-pharmaceuticals-inc-ino-shareholders\\\/\"},\"wordCount\":404,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-inovio-pharmaceuticals-inc-ino-shareholders\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4MzA2NyM3NTE2NjA5IzIwMjA0MjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-inovio-pharmaceuticals-inc-ino-shareholders\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-inovio-pharmaceuticals-inc-ino-shareholders\\\/\",\"name\":\"Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of Inovio Pharmaceuticals, Inc.(INO) Shareholders - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-inovio-pharmaceuticals-inc-ino-shareholders\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-inovio-pharmaceuticals-inc-ino-shareholders\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4MzA2NyM3NTE2NjA5IzIwMjA0MjY=\",\"datePublished\":\"2026-04-06T20:27:30+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-inovio-pharmaceuticals-inc-ino-shareholders\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-inovio-pharmaceuticals-inc-ino-shareholders\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-inovio-pharmaceuticals-inc-ino-shareholders\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4MzA2NyM3NTE2NjA5IzIwMjA0MjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4MzA2NyM3NTE2NjA5IzIwMjA0MjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-inovio-pharmaceuticals-inc-ino-shareholders\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of Inovio Pharmaceuticals, Inc.(INO) Shareholders\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of Inovio Pharmaceuticals, Inc.(INO) Shareholders - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-inovio-pharmaceuticals-inc-ino-shareholders\/","og_locale":"en_US","og_type":"article","og_title":"Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of Inovio Pharmaceuticals, Inc.(INO) Shareholders - Market Newsdesk","og_description":"NEW YORK, April 06, 2026 (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in\u00a0Inovio Pharmaceuticals, Inc. (&#8220;Inovio Pharmaceuticals, Inc.&#8221; or the &#8220;Company&#8221;) (NASDAQ: INO) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Inovio Pharmaceuticals, Inc. investors who were adversely affected by alleged securities fraud between October 10, 2023 and December 26, 2025. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/inovio-pharmaceuticals-inc-lawsuit-submission-form?prid=185172&amp;wire=3 INO investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and\/or concealed that: (i) manufacturing for Inovio\u2019s CELLECTRA device was deficient; &hellip; Continue reading \"Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of Inovio Pharmaceuticals, Inc.(INO) Shareholders\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-inovio-pharmaceuticals-inc-ino-shareholders\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-06T20:27:30+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4MzA2NyM3NTE2NjA5IzIwMjA0MjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-inovio-pharmaceuticals-inc-ino-shareholders\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-inovio-pharmaceuticals-inc-ino-shareholders\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of Inovio Pharmaceuticals, Inc.(INO) Shareholders","datePublished":"2026-04-06T20:27:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-inovio-pharmaceuticals-inc-ino-shareholders\/"},"wordCount":404,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-inovio-pharmaceuticals-inc-ino-shareholders\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4MzA2NyM3NTE2NjA5IzIwMjA0MjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-inovio-pharmaceuticals-inc-ino-shareholders\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-inovio-pharmaceuticals-inc-ino-shareholders\/","name":"Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of Inovio Pharmaceuticals, Inc.(INO) Shareholders - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-inovio-pharmaceuticals-inc-ino-shareholders\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-inovio-pharmaceuticals-inc-ino-shareholders\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4MzA2NyM3NTE2NjA5IzIwMjA0MjY=","datePublished":"2026-04-06T20:27:30+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-inovio-pharmaceuticals-inc-ino-shareholders\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-inovio-pharmaceuticals-inc-ino-shareholders\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-inovio-pharmaceuticals-inc-ino-shareholders\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4MzA2NyM3NTE2NjA5IzIwMjA0MjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4MzA2NyM3NTE2NjA5IzIwMjA0MjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-inovio-pharmaceuticals-inc-ino-shareholders\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of Inovio Pharmaceuticals, Inc.(INO) Shareholders"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/949206","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=949206"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/949206\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=949206"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=949206"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=949206"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}